A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

NCT04187547 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study replaced with a new study

Conditions

Alzheimer's Disease

Interventions

DRUG: Tricaprilin
DRUG: Placebo

Sponsor

Cerecin